Research
- Liver Cancer Vascular & Immune Mapping1.4M cells mapped across 100+ tissue regions; the lab plans to publish the work.
- PD-L1 / TGFBR1 Dual-Inhibition Generative ModelTwo candidate dual-pathway molecules; 4th place, GARSEF Translational Medical Sciences.
- p53–CDKN1A Mutation Binding Model91% accuracy; 3rd at GARSEF, National STEM Festival finalist, MIT THINK commended.
- PD-L1–TGFBR1 Pathway Extension (BioML Society)Extended the dual-inhibition work to cancer stem cells with a UT Austin researcher.